Progression of hypertrophy and myocardial fibrosis in aortic stenosis: a multicenter cardiac magnetic resonance study

RJ Everett, L Tastet, MA Clavel, CWL Chin… - Circulation …, 2018 - Am Heart Assoc
Background: Aortic stenosis is accompanied by progressive left ventricular hypertrophy and
fibrosis. We investigated the natural history of these processes in asymptomatic patients and …

[HTML][HTML] Midwall fibrosis and 5-year outcome in moderate and severe aortic stenosis

VS Vassiliou, A Perperoglou, CE Raphael… - Journal of the American …, 2017 - jacc.org
Aortic stenosis (AS) is characterized by progressive narrowing of the valve and the
hypertrophic response of the left ventricle (LV) that ensues (1). Although initially adaptive …

Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis

F Weidemann, S Herrmann, S Störk, M Niemann… - Circulation, 2009 - Am Heart Assoc
Background—In this prospective follow-up study, the effect of myocardial fibrosis on
myocardial performance in symptomatic severe aortic stenosis was investigated, and the …

[HTML][HTML] Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance

MR Dweck, S Joshi, T Murigu, A Gulati… - Journal of …, 2012 - Elsevier
Background Cardiovascular magnetic resonance (CMR) is the gold standard non-invasive
method for determining left ventricular (LV) mass and volume but has not been used …

Aortic valve area, stroke volume, left ventricular hypertrophy, remodeling, and fibrosis in aortic stenosis assessed by cardiac magnetic resonance imaging: comparison …

G Barone-Rochette, S Piérard, S Seldrum… - Circulation …, 2013 - Am Heart Assoc
Background—Recent works using echocardiography suggested that low gradient (LG), low
flow (LF) aortic stenosis (AS) has more pronounced left ventricular (LV) concentric …

Reverse myocardial remodeling following valve replacement in patients with aortic stenosis

TA Treibel, R Kozor, R Schofield, G Benedetti… - Journal of the American …, 2018 - jacc.org
Background: Left ventricular (LV) hypertrophy, a key process in human cardiac disease,
results from cellular (hypertrophy) and extracellular matrix expansion (interstitial fibrosis) …

Imaging and impact of myocardial fibrosis in aortic stenosis

R Bing, JL Cavalcante, RJ Everett, MA Clavel… - JACC: Cardiovascular …, 2019 - jacc.org
Aortic stenosis is characterized both by progressive valve narrowing and the left ventricular
remodeling response that ensues. The only effective treatment is aortic valve replacement …

[HTML][HTML] Rationale and design of the randomized, controlled early valve replacement guided by biomarkers of left ventricular decompensation in asymptomatic patients …

R Bing, RJ Everett, C Tuck, S Semple, S Lewis… - American Heart …, 2019 - Elsevier
Background The optimal timing of aortic valve replacement in asymptomatic patients with
aortic stenosis is uncertain. Replacement fibrosis, as assessed by midwall (nonischemic) …

Low-gradient aortic valve stenosis: myocardial fibrosis and its influence on function and outcome

S Herrmann, S Störk, M Niemann, V Lange… - Journal of the American …, 2011 - jacc.org
Objectives: This prospective cohort study in patients with aortic stenosis (AS) aimed to
identify surrogates of myocardial fibrosis that are easy to derive in clinical practice, allow the …

Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis

MR Dweck, S Joshi, T Murigu, F Alpendurada… - Journal of the American …, 2011 - jacc.org
Objectives: The goal of this study was to assess the prognostic significance of midwall and
infarct patterns of late gadolinium enhancement (LGE) in aortic stenosis. Background …